Market share liability

China Bicalutamide Market Research Report 2021: Relevant Concepts, Sales 2016-2020, Major Manufacturers, Sales Price 2020-2021, Prospects 2021-2025 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, December 7, 2021
Health, Pharmaceutical, Incidence, The Different Company, China Energy Research Report, Prostate cancer, CAGR, Dosage form, Androgen, COVID-19, Market share liability, AstraZeneca, Environment, Research report, Animal, Pharmaceutical industry, Weapon, Iron, Motor vehicle

The "Research Report on China's Bicalutamide Market, 2021-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Research Report on China's Bicalutamide Market, 2021-2025" report has been added to ResearchAndMarkets.com's offering.
  • China approved the import of bicalutamide tablets under the same brand name in 1999, and later generic drugs by Chinese companies have also been on the market.
  • According to the market research, the sales value of bicalutamide in the Chinese market increased year by year from 2016 to 2019.
  • Local companies with a relatively high share in China's bicalutamide market are Shanxi Zhendong Pharmaceutical, Shanghai Fosun Zhaohui Pharmaceutical, Shanghai Fudan Fuhua Pharmaceutical, and Zhejiang Hisun Pharmaceutical.